J Ling
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 19
- Endocrinology top 2%
- Vibrio bacteria research studies 5
- Escherichia coli research studies 4
- Food Science top 2%
- Salmonella and Campylobacter epidemiology 15
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 5
-
- Diabetes Management and Research 6
-
- Antimicrobial Resistance in Staphylococcus 4
-
- Listeria monocytogenes in Food Safety 4
- Co-authors
- A. F. B. ChengG.L. FrenchEdward Wai‐Chi ChanYujuan JinK M KamThomas K.�W. LingP. Y. ChauS. Donnan
- Journals
- Journal of Antimicrobial Chemotherapy (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Epidemiology and Infection (3 papers)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
J Ling
52 papers receiving 843 citations
Peers
Comparison fields: 5 of 97
- Molecular Medicine 358
- Endocrinology 206
- Applied Microbiology and Biotechnology 52
- Food Science 337
- Clinical Biochemistry 114
Countries citing papers authored by J Ling
This map shows the geographic impact of J Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Ling more than expected).
Fields of papers citing papers by J Ling
This network shows the impact of papers produced by J Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Ling. The network helps show where J Ling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 38 | |
| 9 | 2017 | 1 | |
| 10 | 2013 | 11 | |
| 11 | 2012 | 9 | |
| 12 | 2009 | 12 | |
| 13 | 2003 | 9 | |
| 14 | 2001 | 17 | |
| 15 | 1999 | 36 | |
| 16 | 1997 | 1 | |
| 17 | Pathogenic Vibrio spp. in the Sea Bream, Sparus sarba | 1995 | 8 |
| 18 | 1993 | 16 | |
| 19 | 1988 | 21 | |
| 20 | 1988 | 11 |
About J Ling
J Ling is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Food Science and Clinical Biochemistry, having authored 56 papers that have together received 921 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Salmonella and Campylobacter epidemiology (15 papers), Diabetes Management and Research (6 papers), Vibrio bacteria research studies (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Escherichia coli research studies (4 papers) and Listeria monocytogenes in Food Safety (4 papers). The work is most often cited by research in Molecular Medicine (358 citations), Endocrinology (206 citations), Applied Microbiology and Biotechnology (52 citations), Food Science (337 citations) and Clinical Biochemistry (114 citations). J Ling has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include A. F. B. Cheng, G.L. French, Edward Wai‐Chi Chan, Yujuan Jin, K M Kam, Thomas K.�W. Ling, P. Y. Chau, S. Donnan, M. Farrington and Elaine Chow. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Epidemiology and Infection, Journal of Clinical Pathology and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.